United Therapeutics Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
UTHR Nasdaq 2830 www.unither.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for United Therapeutics Corporation

Is MannKind Corporation (MNKD) A Good Stock To Buy Now? - Jun 29th, 2026 1:35 pm
United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion - Jun 29th, 2026 4:30 am
Bull of the Day: Neurocrine Biosciences (NBIX) - Jun 29th, 2026 2:00 am
Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks - Jun 22nd, 2026 12:43 pm
These 3 Stocks Lowered Their Share Counts Drastically in Q1 - Jun 9th, 2026 7:35 am
A Look At United Therapeutics (UTHR) Valuation After Strong Long Term Shareholder Returns - Jun 5th, 2026 5:10 pm
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report? - Jun 5th, 2026 9:30 am
How The Story Around United Therapeutics (UTHR) Is Shifting On Trials Pricing And Valuation - Jun 5th, 2026 7:16 am
SDZNY or UTHR: Which Is the Better Value Stock Right Now? - Jun 4th, 2026 9:40 am
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore - Jun 3rd, 2026 8:31 am
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year - May 30th, 2026 11:56 am
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock - May 30th, 2026 9:50 am
2 Mid-Cap Stocks on Our Buy List and 1 We Turn Down - May 29th, 2026 4:40 am
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside - May 28th, 2026 2:27 pm
Pulmonary Arterial Hypertension Market Outlook Shows Strong Upward Trend at a CAGR of 6.7% During the Study Period (2022-2036) Supported by New Clinical Developments | DelveInsight - May 25th, 2026 3:31 pm
United Therapeutics Explores Pig Heart Transplants And Space Labs As Valuation Lags - May 22nd, 2026 12:14 am
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026 - May 18th, 2026 2:15 pm
MannKind Corp. (MNKD) Reports Q1 2026 Total Revenues of $90.2M - May 17th, 2026 10:50 pm
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026 - May 17th, 2026 12:15 pm
5 Insightful Analyst Questions From United Therapeutics’s Q1 Earnings Call - May 16th, 2026 8:44 am